JPH0566825B2 - - Google Patents

Info

Publication number
JPH0566825B2
JPH0566825B2 JP62128473A JP12847387A JPH0566825B2 JP H0566825 B2 JPH0566825 B2 JP H0566825B2 JP 62128473 A JP62128473 A JP 62128473A JP 12847387 A JP12847387 A JP 12847387A JP H0566825 B2 JPH0566825 B2 JP H0566825B2
Authority
JP
Japan
Prior art keywords
current
expectorant
setting
conductor
carrier wave
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP62128473A
Other languages
Japanese (ja)
Other versions
JPS63292968A (en
Inventor
Ryozo Hasegawa
Toshimi Nishama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP62128473A priority Critical patent/JPS63292968A/en
Priority to EP88301823A priority patent/EP0293068A1/en
Publication of JPS63292968A publication Critical patent/JPS63292968A/en
Priority to US07/605,938 priority patent/US5123413A/en
Publication of JPH0566825B2 publication Critical patent/JPH0566825B2/ja
Granted legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E60/00Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
    • Y02E60/10Energy storage using batteries

Landscapes

  • Electrotherapy Devices (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

〔産業上の利用分野〕 本発明は、慢性気管支炎、細気管支炎、気管支
喘息、気管支拡張症、肺結核症、及び肺気腫等の
呼吸器疾患において、喀痰喀出困難な患者の去痰
援助をなす治療器に関する。さらに詳しくは干渉
低周波電気治療器であつて、電気刺激を胸部の気
管及び気管支に与え、滞留している喀痰の喀出を
容易となす治療器に関する。 〔従来技術〕 近年、人口の増加と老令化、大気汚染等の生活
環境の変化に伴い、慢性気管支炎、気管支喘息、
肺気腫等の慢性呼吸器疾患患者が増加の傾向にあ
る。これらの吸器器疾患に随伴する症状である
痰、咳、息切れ等のうち特に喀出困難は、診療上
頻度多くみられる症状であり、特に慢性閉塞性肺
疾患、例えばば慢性気管支炎、気管支喘息、肺気
腫等では吸困難とともに主要な症状のひとつとな
つている。呼吸器疾患の治療上、呼吸不全、気道
感染等が発現しやすい痰を除去することは非常に
重要であつて、その為の去痰方法として薬物療法
と理学療法がある。 薬物療法における去痰薬として、例えばヨード
塩類、ベンジルアミン類、酵素剤、システイン系
製剤、アレベール等が知られている。かかる去痰
薬は、何れも痰の粘着、曵糸性、チクソトロピー
現象等のレオロジー特性に対して直接的あるいは
間接的に作用するものであるが、薬物投与の性質
上その副作用が避けがたく、人体に悪影響を及ぼ
すことが多い。また薬物では充分な去痰ができな
い症例も多々ある。 他方、理学療法としては休止排痰法(ドレナー
ジ)が知られている。この治療法は、患者の体全
体又は胸部を傾けて喀痰が重力で排出してくるよ
うになす。加えて胸壁を軽く叩いたり(クラツピ
ング及びタツピング)、また胸部を外部から振動
させたり(バイブレーシヨン)することにより喀
痰を喀出しやすくする方法である。しかしなが
ら、前記薬物療法の副作用の心配が少ない反面、
充分な痰の喀出効果がにくい欠点を有している。 さらに理学療法の一種として、径気道的に10Hz
以下の圧波を直接気道、気管に送り込み排痰を促
進する方法が提案されているが、さらに改善が必
要とされている。 本発明者らの一部は、全く新しい理学的法痰方
法として、電流治療器であつて知周波を発生しう
る呼吸機能及び/又は症状改善用治療器を用いる
去痰方法を開示した(特開昭60−31766号公報)
が、干渉低周波電気刺激による喀痰喀出効果は、
電気刺激条件及び治療位置により大きく異なり、
さらに鋭意研究を行ない、本発明を完成するに至
つた。 〔発明の目的〕 本発明の目的は、呼吸器疾患の喀痰喀出困難な
患者の去痰援助をより確実に且つ安全に行なうた
めの治療器を提供することである。 〔発明の構成〕 かかる目的を達成すべく本発明者らは干渉低周
波電気刺激により胸部の気管及び気管支に滞留し
ている喀痰の喀出を容易となす条件及び治療位置
について検討を加え、優れた去痰効果を見出すこ
とにより、本発明の治療器を完成するに至つた。 すなわち、本発明は中程度の周波数を有し周波
数差が30〜150Hzである2種の搬送波電流を発生
するための電流発生手段と、第2種の搬送波電流
の各々を通電するための2対の導子手段と、通電
時の電流を検出するための電流検出手段と、該通
電時の電流を6mA以上に調節するための電流調
節手段、及び通電時間を設定するための時間設定
手段を有し、該2対の導子手段が各対の導子手段
の端部を形成する電極の一方を胸部に他方を背部
に設置せしめ且つ各対の導子手段からの電流が互
いに交差するように該電極の各々を位置せしめる
ものである去痰用電気治療器を提供するものであ
る。 以下、本発明の電気治療器について、必要に応
じて図面を用いながらさらに詳細に説明する。第
1図に本発明の電気治療器の好ましい実施態様の
1例をブロツク図により模式的に示したものであ
る。同図において電流発生手段1は搬送波発振器
2と治療波発振器3及び移相器4からなる。また
他の例として、異なる周波数の2個の搬送波発振
器を用いて電流発生手段としてもよい。本発明に
言う中程度の周波数として、1000Hzのオーダーの
ものが好ましく、具体例としては、3000〜5000Hz
程度の領域が実用上用いられる。さらに具体的に
は、4000Hz近傍が、人体皮膚の電気インピーダン
スが低く、身体に通電しやすいこと、及び生体へ
の電気シヨツク(マクロシヨツク)に関して商用
流(50ないし60Hz)より格段に閾値が高く、安全
なことから使用される。。干渉低周波として本例
で再現する治療周波数は30Hzから、150Hzの範囲
内で発振させることが望ましく、その場合には移
相器4により一方の搬送波を、例えば4000+100
=4100Hzとする。この4100Hzの搬送波とと、他の
4000Hzの搬送波2対の導子8を介して各々2個の
端子から出力し、生体での4個の電極9から通電
加療を行うことができる。 また第1図に示す如く、本発明の電気治療器は
2対の電極9を通じて流れる電流を検出する電流
検出手段6及び検出された電流を表示する電流表
示手段7を備え、さらに電流を調節するための電
流調節手段や通電時間の設定手段を含む調節手段
5を有している。尚電流調節手段の具体例として
は、出力増巾器の増巾度を変える手段や、出力抵
抗器の抵抗値を変える手段等があげられる。 第2図で例示するように、人体の胸部2ケ所、
背部2ケ所の電極は、A−A′対とB−B′対が交
差するように取付ける。A−A′とB−B′の交差
点から干渉低周波、本例では100Hzのものが生体
内に発現する。この干渉低周波電気刺激が、驚く
べきことに優れた去痰援助作用をもたらしたので
ある。 作用機序としては、干渉低周波電気刺激が気道
液分泌を亢進し、喀痰そのもののレオロジカルな
性状を流れ易く変化させ、加えて気管の粘液線毛
輸送速度を向上して、全体として喀痰喀出効果を
もたらすことが、動物実験から認められた。そこ
で、人体に対してこの去痰作用をいかに応用すべ
きか、効果及び不都合な点から検討を進めた。 干渉低周波の周波数は後述する如く痰の切れか
らみた全般改度の結果から30〜150Hzの範囲内が
よい。30Hz未満では刺激が強すぎて場合によつて
は不快である。150Hzを越えると去痰効果が下が
る。特に好ましくは50〜100Hzである。 加療電流値の下限については、3mA未満では
電気刺激があまり感じられず、5mA未満では去
痰効果が得られにくいこととら、6mA以上であ
る必要がある。また、加療電流値の上限について
は、去痰効果の程度よりも人体に対する電気刺激
激による影響の方が問題にりやすく、例えば
50mA以上では相当に電気刺激が強く感じられ筋
肉等がれん縮する傾向もみられ、患者に不安感を
与えるので好ましくない。かかる上限について
は、個人差もあり一概に言えず、使用者に応じて
その値を設定することが、本発明の治療器を使用
する者に対する安全対策上特に好ましい。 尚、かかる安全対策上、本発明の去痰用電気治
療器においては、通電時の電流の上限を設定して
おき、その上限よりも通電電流が高くなつた場合
に自動的にその電流を低下せしめる(即ち第1図
における増巾器等の電流調節手段を調節する)か
通電を停止するための過剰電流防止手段を例えば
第1図の調節手段5に組み込むことが望ましい。
さらには、その電流の上限を使用する者の適性に
応じて設定し得るようにしたものの方が実用上有
用である。 通電加療時間は5〜30分の範囲内で選ぶことが
できる。去痰作用は干渉低周波電気刺激が副交感
神経系を介して、前記作用機序で働くと考えら
れ、臨床でも加療中から数時間ないし十数時間持
続することが認められた。よつて生体が電気刺激
を充分に受容できる時間として、加療時間は好ま
しくは10から20分間の範囲内である。 左胸部と右背部の電極対(第2図のB−B′対)
及び右胸部と左背部の電極対(第2図A−A′対)
から異なる周波数、例えば4000Hzと4100Hzの2つ
の搬送波を通電加療すると、干渉波として100Hz
の電気刺激が去痰作用をもたらす。 第1図に示した実施態様の装置の場合、例えば
3000から5000Hzの範囲内の2つの搬送波を供給す
る手段とそれら周波数差を発振する手段が必要で
あり、搬送波発振器、治療波発振器、移相器、及
び出力増幅器として構成される。別な態様とし
て、始めから2つの搬送波を独立に発振して増幅
して供給する発振器及び増幅器から構成してもよ
い。何れの場合も治療波すなわち干渉低周波の周
波数を30から150Hzの範囲内に設定できる手段と
出力電流を制御する手段を付設する。また通電加
療時間を設定するタイマー手段を付設する。 第2図に示すように胸部に2箇所及び背部に2
箇所に導子電極を装着する手段として粘着導電導
子、含水スポンジ導子固定帯及び固定具を用いる
ことができる。この様に真空ポンプによる吸引力
によらずに導子を固定するものであれば、治療器
全体がコンパクトにできるので、携帯用としても
使用できるので実用上非常に有用である。 以下実施例ををあげて、本発明をさらに詳細に
説明するが、本発明の治療器はそれらの実施例に
より何ら限定されるものではない。 実施例 1 男性42名、女性61名計103名の慢性気管支炎
(56例)、気管支喘息(19例)、細気管支炎(11
例)、及び肺気腫(7例)等の「痰が切れにくい」
と訴える慢性呼吸器疾患の患者に対して、ミナト
医科学社製SKを150Hzまで出力し得るように改良
した本発明の実施態様である干渉低周波去痰治療
器を用い中吸引スポンジ導子電極を胸背部に装着
し、50、70、100及び150Hzで10分間加療した。結
果を第1表及び第2表に示すが、著明改善(痰の
切れが2段階以上改善)が11例(10.7%)、中等
度改善(痰の切れが1段階改善)29例(28.1%)、
軽度改善(痰の切れは1段階改善に至らないが、
その他の症状が改善)40例(38.9%)であつた。
よつて軽度改善以上は77.7%で優れた去痰効果を
示した。
[Industrial Application Field] The present invention is a therapeutic device for assisting expectoration in patients who have difficulty coughing up sputum in respiratory diseases such as chronic bronchitis, bronchiolitis, bronchial asthma, bronchiectasis, pulmonary tuberculosis, and emphysema. Regarding. More specifically, the present invention relates to an interference low-frequency electrical therapy device that applies electrical stimulation to the trachea and bronchi of the chest to facilitate the expectoration of accumulated sputum. [Prior art] In recent years, with the increase and aging of the population and changes in the living environment such as air pollution, chronic bronchitis, bronchial asthma,
The number of patients with chronic respiratory diseases such as emphysema is on the rise. Among the symptoms associated with these tract diseases, such as phlegm, cough, and shortness of breath, difficulty in expectoration is a symptom that is frequently seen in clinical practice, and is especially common in patients with chronic obstructive pulmonary disease, such as chronic bronchitis, bronchial asthma, etc. It is one of the main symptoms of emphysema, etc., along with difficulty in breathing. In the treatment of respiratory diseases, it is very important to remove phlegm, which is likely to cause respiratory failure, respiratory tract infection, etc., and drug therapy and physical therapy are available as expectoration methods for this purpose. Known expectorants used in drug therapy include, for example, iodo salts, benzylamines, enzyme agents, cysteine preparations, and allevert. All of these expectorants act directly or indirectly on the rheological properties of sputum, such as stickiness, stringiness, and thixotropy, but due to the nature of drug administration, side effects are unavoidable, and they are harmful to the human body. often have a negative impact on In addition, there are many cases in which drugs are not sufficient to remove sputum. On the other hand, a paused sputum drainage method (drainage) is known as physical therapy. This treatment involves tilting the patient's entire body or chest so that sputum can be expelled by gravity. In addition, this method makes it easier to expectorate sputum by tapping the chest wall lightly (clapping and tapping) or by vibrating the chest from the outside (vibration). However, while there is less concern about the side effects of the drug therapy,
It has the disadvantage that it is difficult to expectorate enough phlegm. In addition, as a type of physical therapy, 10Hz in the airway
The following method of sending pressure waves directly into the airways and trachea to promote sputum clearance has been proposed, but further improvements are needed. Some of the present inventors have disclosed a completely new physical sputum removal method using a treatment device for improving respiratory function and/or symptoms, which is an electric current therapy device that can generate known frequency waves (Unexamined Japanese Patent Publication No. Publication number 60-31766)
However, the sputum expectoration effect due to interference low-frequency electrical stimulation is
It varies greatly depending on the electrical stimulation conditions and treatment location.
Further extensive research has led to the completion of the present invention. [Object of the Invention] An object of the present invention is to provide a treatment device for more reliably and safely assisting patients with respiratory diseases who have difficulty coughing up sputum. [Structure of the Invention] In order to achieve the above object, the present inventors have investigated conditions and treatment positions that facilitate the expectoration of sputum accumulated in the trachea and bronchi of the chest using interference low-frequency electrical stimulation, and have found an excellent treatment position. By discovering the expectorant effect, we have completed the therapeutic device of the present invention. That is, the present invention includes current generating means for generating two types of carrier wave currents having a medium frequency and a frequency difference of 30 to 150 Hz, and two pairs for energizing each of the second type of carrier wave currents. conductor means, current detection means for detecting the current when energized, current adjustment means for adjusting the current at 6 mA or more when energized, and time setting means for setting the energization time. and the two pairs of conductor means are such that one of the electrodes forming the ends of each pair of conductor means is placed on the chest and the other on the back, and the currents from each pair of conductor means cross each other. The present invention provides an electric treatment device for expectoration in which each of the electrodes is positioned. Hereinafter, the electric treatment device of the present invention will be described in further detail using the drawings as necessary. FIG. 1 is a block diagram schematically showing one example of a preferred embodiment of the electric therapy device of the present invention. In the figure, the current generating means 1 includes a carrier wave oscillator 2, a therapeutic wave oscillator 3, and a phase shifter 4. As another example, two carrier wave oscillators with different frequencies may be used as the current generating means. The medium frequency referred to in the present invention is preferably on the order of 1000Hz, and a specific example is 3000 to 5000Hz.
A range of degrees is used in practice. More specifically, around 4000Hz, the electrical impedance of the human skin is low and it is easy to conduct electricity to the body, and the threshold for electrical shocks (macroshocks) to living organisms is much higher than commercial currents (50 to 60Hz). It is used because it is safe. . It is desirable that the treatment frequency reproduced in this example as the interference low frequency be oscillated within the range of 30Hz to 150Hz.
=4100Hz. This 4100Hz carrier wave and other
A carrier wave of 4000 Hz is outputted from two terminals each through two pairs of conductors 8, and electrical treatment can be performed from four electrodes 9 on a living body. Further, as shown in FIG. 1, the electric therapy device of the present invention includes current detection means 6 for detecting the current flowing through the two pairs of electrodes 9 and current display means 7 for displaying the detected current, and further includes a current display means 7 for displaying the detected current. It has adjustment means 5 including current adjustment means and means for setting energization time. Specific examples of the current adjusting means include means for changing the amplification degree of an output amplifier, means for changing the resistance value of an output resistor, and the like. As illustrated in Figure 2, two locations on the chest of the human body,
The two electrodes on the back are attached so that the A-A' pair and the B-B' pair intersect. From the intersection of A-A' and B-B', an interference low frequency, in this example 100 Hz, is generated in the living body. Surprisingly, this interferometric low-frequency electrical stimulation produced an excellent expectorant aid effect. The mechanism of action is that interferometric low-frequency electrical stimulation increases airway fluid secretion, changes the rheological properties of sputum itself to make it easier to flow, and also improves mucociliary transport speed in the trachea, resulting in improved sputum production as a whole. Animal experiments have shown that it is effective. Therefore, we investigated how to apply this expectorant effect to the human body, considering its effects and disadvantages. The frequency of the interference low frequency is preferably within the range of 30 to 150 Hz based on the results of general modification from the perspective of cutting phlegm, as will be described later. Below 30Hz, the stimulation is too strong and may be uncomfortable in some cases. When the frequency exceeds 150Hz, the expectorant effect decreases. Particularly preferably 50 to 100 Hz. The lower limit of the therapeutic current value needs to be 6 mA or more, since electrical stimulation is not felt much when it is less than 3 mA, and it is difficult to obtain an expectorant effect when it is less than 5 mA. Regarding the upper limit of the treatment current value, the influence of intense electrical stimulation on the human body is more likely to be a problem than the degree of expectorant effect, for example.
At 50 mA or more, the electric stimulation is felt to be quite strong and there is a tendency for muscles etc. to twitch, which is undesirable because it gives the patient a sense of anxiety. The upper limit cannot be generalized due to individual differences, and it is particularly preferable to set the upper limit depending on the user in terms of safety for those using the therapeutic device of the present invention. In addition, for such safety measures, in the expectoration electric therapy device of the present invention, an upper limit of the current during energization is set, and when the energized current becomes higher than the upper limit, the current is automatically reduced. It is desirable to incorporate, for example, into the adjustment means 5 of FIG. 1, excessive current prevention means for stopping the current supply (that is, adjusting the current adjustment means such as the amplifier shown in FIG. 1) or stopping the current supply.
Furthermore, it would be more practically useful if the upper limit of the current could be set according to the suitability of the user. The electrical treatment time can be selected within the range of 5 to 30 minutes. The expectorant effect is thought to be caused by interference low-frequency electrical stimulation via the parasympathetic nervous system and by the above-mentioned mechanism of action, and it has been observed in clinical practice that it lasts from several hours to more than ten hours during treatment. Therefore, the treatment time is preferably within the range of 10 to 20 minutes, which is the time during which the living body can sufficiently receive the electrical stimulation. Electrode pair on the left chest and right back (B-B' pair in Figure 2)
and electrode pairs on the right chest and left back (Fig. 2 A-A' pair)
When two carrier waves of different frequencies, for example 4000Hz and 4100Hz, are energized and treated, an interference wave of 100Hz is generated.
Electrical stimulation produces an expectorant effect. In the case of the apparatus of the embodiment shown in FIG. 1, for example
Means for supplying two carrier waves in the range of 3000 to 5000 Hz and means for oscillating their frequency difference are required, and are configured as a carrier wave oscillator, a therapeutic wave oscillator, a phase shifter, and an output amplifier. Alternatively, it may be constructed from an oscillator and an amplifier that independently oscillate and amplify two carrier waves from the beginning. In either case, means for setting the frequency of the therapeutic wave, that is, the interference low frequency wave, within the range of 30 to 150 Hz, and means for controlling the output current are provided. Additionally, a timer means for setting the energization treatment time is attached. As shown in Figure 2, there are two locations on the chest and two locations on the back.
Adhesive conductive conductors, hydrous sponge conductor fixing bands, and fixtures can be used as means for attaching conductor electrodes to locations. In this way, if the conductor is fixed without relying on the suction force of a vacuum pump, the entire treatment device can be made compact and can be used as a portable device, which is very useful in practice. The present invention will be explained in more detail with reference to Examples below, but the therapeutic device of the present invention is not limited to these Examples in any way. Example 1 A total of 103 patients, 42 men and 61 women, were diagnosed with chronic bronchitis (56 cases), bronchial asthma (19 cases), and bronchiolitis (11 cases).
example), and “difficulty cutting phlegm” such as emphysema (7 cases)
For patients with chronic respiratory diseases who complain of this, we used an interference low-frequency expectorator treatment device, which is an embodiment of the present invention, which is an improved SK manufactured by Minato Medical Science Co., Ltd. that can output up to 150 Hz, and a medium suction sponge conductor electrode. It was attached to the back of the chest and treated at 50, 70, 100 and 150Hz for 10 minutes. The results are shown in Tables 1 and 2. 11 cases (10.7%) had marked improvement (sputum clearance improved by 2 or more levels), and 29 cases (28.1%) moderate improvement (1 level improvement in sputum clearance). %),
Mild improvement (sputum clearance has not improved by one level, but
Other symptoms improved in 40 cases (38.9%).
Therefore, 77.7% of patients showed mild improvement or better, demonstrating excellent expectorant effects.

【表】【table】

【表】【table】

【表】 (ロ) 患者印象
AA:非常によかつた
A:よかつた
実施例 2 男91名、女45名計136名の慢性気管支炎(29
例)、細気管支炎(20例)、気管支喘息(35例)、
気管支拡張症(17例)、肺結核症(8例)、肺気腫
(14例)等の喀痰喀出困難な慢性呼吸器疾患の患
者に対して、50、70、100Hzを出力し得る本発明
の実施態様である干渉低周波去痰治療器を用い粘
着導子を胸背部に装着し70Hzで10分間加療した。
加療電流値は3〜24mAの範囲内であり、平均
13.6±2.8(標準偏差)mAであつた。その結果を
を第3表に示すが、著明改善はI群の疾患で13例
(15.5%)、の疾患群で2例(3.6%)計15例
(11.0%)であつた。中等度改善は群で29例
(34.5%)、群で7例(13.5%)、計36例(26.5
%)であつた。軽度改善は群で28例(33.3%)、
群で12例(23.1%)、計40例(29.4%)であつ
た。よつて軽度改善以上は、群で83.3%、群
で40.4%、計68.9%で優れた去痰効果を示した。。
とくに群の疾患に対しては去痰薬と同等以上の
効果を示した。また加療電流値と改善度の関係を
表わすと第3図の如くなり、6mA以上で効果が
発現されることがうかがわれる。尚約24mAの電
流値については、症例数が少ないが、効果のある
こと確かめられた。
[Table] (B) Patient impression
AA: Very good
A: Good Example 2 A total of 136 patients with chronic bronchitis (29
e.g.), bronchiolitis (20 cases), bronchial asthma (35 cases),
Embodiments of the present invention capable of outputting 50, 70, and 100 Hz for patients with chronic respiratory diseases that make it difficult to cough up sputum, such as bronchiectasis (17 cases), pulmonary tuberculosis (8 cases), and emphysema (14 cases) Using an interference low-frequency expectorant treatment device, an adhesive guide was attached to the back of the chest and treatment was performed at 70Hz for 10 minutes.
The treatment current value is within the range of 3 to 24 mA, and the average
It was 13.6±2.8 (standard deviation) mA. The results are shown in Table 3. Significant improvement was observed in 13 patients (15.5%) in group I disease and 2 patients (3.6%) in group I disease, for a total of 15 patients (11.0%). Moderate improvement was achieved in 29 patients (34.5%) in the group and 7 patients (13.5%) in the group, for a total of 36 patients (26.5%).
%). Mild improvement occurred in 28 patients (33.3%) in the group;
There were 12 patients (23.1%) in the group, and a total of 40 patients (29.4%). Therefore, 83.3% of the groups showed mild improvement or better, and 40.4% of the groups showed excellent expectorant effects in a total of 68.9%. .
In particular, it was shown to be as effective as or more effective than expectorants against certain diseases. Furthermore, the relationship between the treatment current value and the degree of improvement is shown in Fig. 3, and it can be seen that the effect is expressed at 6 mA or more. Regarding the current value of approximately 24 mA, although the number of cases was small, it was confirmed that it is effective.

〔発明の効果〕〔Effect of the invention〕

本発明の去痰用電気治療器は、実施例に示す如
く去痰薬と同等以上の去痰効果を示し得るもので
ある。尚咳が寛解すること及び呼吸筋の疲労が寛
解する副次効果の得られる場合もある。即ち本発
明の治療器は、慢性呼吸器疾患患者の喀痰喀出困
難に対して去痰援助を安全かつ確実になすもので
あつて、医療及び医療産業に資すること大なるも
のである。
As shown in the examples, the expectorant electric therapy device of the present invention can exhibit an expectorant effect equal to or higher than that of an expectorant. In some cases, side effects such as remission of cough and remission of respiratory muscle fatigue may be obtained. That is, the therapeutic device of the present invention safely and reliably provides expectoration assistance to patients with chronic respiratory diseases who have difficulty coughing up sputum, and is of great benefit to medical care and the medical industry.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明の治療器のブロツク図である。
第2図は導子電極の装着位置例を示す。第3図は
全般改善度と加療電流値の関係を示す。
FIG. 1 is a block diagram of the treatment device of the present invention.
FIG. 2 shows an example of the mounting position of the conductor electrode. FIG. 3 shows the relationship between the degree of overall improvement and the therapeutic current value.

Claims (1)

【特許請求の範囲】 1 中程度の周波数を有し周波数差が30〜150Hz
である2種の搬送波電流を発生するための電流発
生手段と、該2種の搬送波電流の各々を通電する
ための2対の導子手段と、通電時の電流を検出す
るための電流検出手段と、該通電時の電流を
6mA以上に調節するための電流調節手段、及び
通電時間を設定するための時間設定手段を有し、
該2対の導子手段が各対の導子手段の端部を形成
する電極の一方を胸部に他方を背部に設置せしめ
且つ各対の導子手段からの電流が互いに交差する
ように該電極の各々を位置せしめるものである去
痰用電気治療器。 2 該電流発生手段が、周波数差50〜100Hzの2
種の搬送波電流を生ずるものである特許請求の範
囲第1項記載の去痰用電気治療器。 3 該時間設定手段が、通電時間を5〜30分の範
囲内に設定し得るものである特許請求の範囲第1
項記載の去痰用電気治療器。 4 該電流検出手段が通電時の電流の上限を越え
た電流を検出した際に、通電電流を低下又は停止
させる過剰電流防止手段を備えた特許請求の範囲
第1項記載の去痰用電気治療器。 5 該過剰電流防止手段が、該過電時の電流の上
限を設定する手段を有するものである特許請求の
範囲第4項記載の去痰用電気治療器。
[Claims] 1. Has a medium frequency and has a frequency difference of 30 to 150 Hz.
current generating means for generating two types of carrier wave currents, two pairs of conductor means for passing each of the two types of carrier wave currents, and current detecting means for detecting the current when energized. And the current when the current is applied is
It has a current adjustment means for adjusting the current to 6mA or more, and a time setting means for setting the energization time,
The two pairs of conductor means are arranged such that the electrodes forming the ends of each pair of conductor means are placed one on the chest and the other on the back and such that the currents from each pair of conductor means cross each other. An electric treatment device for expectoration that positions each of the above. 2. The current generating means has a frequency difference of 50 to 100 Hz.
2. The expectorant electric therapy device according to claim 1, which generates a carrier wave current of a certain amount. 3. Claim 1, wherein the time setting means is capable of setting the energization time within a range of 5 to 30 minutes.
Electrotherapeutic device for expectoration as described in section. 4. The expectorant electric therapy device according to claim 1, which is equipped with excessive current prevention means that reduces or stops the applied current when the current detection means detects a current that exceeds the upper limit of the current when applied. . 5. The expectorant electric therapy device according to claim 4, wherein the excessive current prevention means has means for setting an upper limit of the current at the time of the overcurrent.
JP62128473A 1987-05-27 1987-05-27 Electric treatment device for removing sputum Granted JPS63292968A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP62128473A JPS63292968A (en) 1987-05-27 1987-05-27 Electric treatment device for removing sputum
EP88301823A EP0293068A1 (en) 1987-05-27 1988-03-02 An electric therapeutic apparatus
US07/605,938 US5123413A (en) 1987-05-27 1990-10-30 Electric therapeutic apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62128473A JPS63292968A (en) 1987-05-27 1987-05-27 Electric treatment device for removing sputum

Publications (2)

Publication Number Publication Date
JPS63292968A JPS63292968A (en) 1988-11-30
JPH0566825B2 true JPH0566825B2 (en) 1993-09-22

Family

ID=14985600

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62128473A Granted JPS63292968A (en) 1987-05-27 1987-05-27 Electric treatment device for removing sputum

Country Status (1)

Country Link
JP (1) JPS63292968A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200139333A (en) * 2019-06-04 2020-12-14 영남대학교 산학협력단 Sputum removal assist apparatus

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02206475A (en) * 1989-02-06 1990-08-16 Teijin Ltd Electric treatment device for constipation
FR2713093B1 (en) * 1993-12-01 1996-04-12 Gelec Sarl Device for controlling electrical stimulation of biological tissues.
WO2011162174A1 (en) * 2010-06-21 2011-12-29 ヤーマン株式会社 High-frequency treatment device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200139333A (en) * 2019-06-04 2020-12-14 영남대학교 산학협력단 Sputum removal assist apparatus

Also Published As

Publication number Publication date
JPS63292968A (en) 1988-11-30

Similar Documents

Publication Publication Date Title
US5123413A (en) Electric therapeutic apparatus
US5190036A (en) Abdominal binder for effectuating cough stimulation
JP2020022781A5 (en)
DiMarco et al. Combined intercostal and diaphragm pacing to provide artificial ventilation in patients with tetraplegia
JP2022532375A (en) Systems and methods for detection and stimulation
US20080021506A1 (en) Method and device for the electrical treatment of sleep apnea and snoring
US20060276701A1 (en) Detection and stimulus conditioning system for sleep apnea
KR101551157B1 (en) Swallowing assistance device
JPH06504220A (en) Electrical sublingual stimulation method and device
KR20110049774A (en) Nose stimulator for producing a stimulation signal to a nose
JPH0222674B2 (en)
De Troyer et al. Triangularis sterni muscle use in supine humans
DiMarco Neural prostheses in the respiratory system.
White New therapies for obstructive sleep apnea
JPH0566825B2 (en)
US20040044338A1 (en) Methods and systems for administering microcurrent therapy for treatment and prevention of side effects associated with cancer treatment
JP2971214B2 (en) Low frequency electric therapy equipment
Zhang et al. Functional magnetic stimulation of inspiratory and expiratory muscles in subjects with tetraplegia
JPS6031766A (en) Current treating device for improving breathing function
JPH01139078A (en) Apparatus for electrotherapy
JP2016182317A (en) Respiratory tract securing apparatus
JPH02206475A (en) Electric treatment device for constipation
RU2169592C2 (en) Method for preventing and treating respiratory disorders
RU2530669C1 (en) Method of treating mucoviscidosis in children
WO2023234274A1 (en) Oral muscle training instrument and oral muscle training method

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20070922

Year of fee payment: 14